BioCentury
ARTICLE | Financial News

ConjuChem files for follow-on

May 30, 2001 7:00 AM UTC

ConjuChem (TSE:CJC), which develops modified versions of existing drugs, filed to sell up to 3 million shares in a follow-on. The deal will be underwritten by Yorkton; BMO Nesbitt Burns; and HSBC. Fou...